Why Buffett, Bezos, & Congress Are Piling Into This One Sector

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…

MURA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.06%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $69,126.19

Mural Oncology Insider Trading History Chart

Mural Oncology Share Price & Price History

^$3.46

▼ -0.06 (-1.70%)

As of 11/1/2024 01:00 AM ET

Days: 30 | 90 | 365

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

Mural Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/31/2024	Adam D Cutler	CFO	Sell	7,421	$3.41	$25,305.61	71,438
7/18/2024	Maiken Keson-Brookes	Insider	Sell	2,157	$3.41	$7,355.37	43,850
7/8/2024	Caroline Loew	CEO	Sell	12,531	$2.91	$36,465.21	240,391

Watch this before it gets removed

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Mural Oncology (NASDAQ:MURA)

80.21% of Mural Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Mural Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Cubist Systematic Strategies LLC	31,243	$98K	0.0%	N/A	0.185%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	26,642	$84K	0.0%	N/A	0.157%
8/15/2024	Armistice Capital LLC	1,688,000	$5.30M	0.1%	N/A	9.974%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	26,642	$84K	0.0%	N/A	0.157%
8/14/2024	Squarepoint Ops LLC	167,644	$0.53M	0.0%	N/A	0.991%
8/14/2024	Cubist Systematic Strategies LLC	31,243	$98K	0.0%	N/A	0.185%
8/13/2024	Canada Pension Plan Investment Board	22,360	$70K	0.0%	N/A	0.132%
8/9/2024	Primecap Management Co. CA	235,551	$0.74M	0.0%	N/A	1.392%
8/9/2024	Renaissance Technologies LLC	232,100	$0.73M	0.0%	N/A	1.371%
8/9/2024	Dimensional Fund Advisors LP	22,563	$71K	0.0%	N/A	0.133%
8/8/2024	Nicollet Investment Management Inc.	98,016	$0.31M	0.1%	N/A	0.579%
8/6/2024	Acadian Asset Management LLC	318,536	$1M	0.0%	N/A	1.882%
8/5/2024	BBR Partners LLC	10,000	$31K	0.0%	N/A	0.059%
8/1/2024	Rhumbline Advisers	10,786	$34K	0.0%	N/A	0.064%
7/9/2024	Harbor Capital Advisors Inc.	36,769	$0.12M	0.0%	N/A	0.217%

Data available starting January 2016

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.

Today's Range

Now: $3.46

$3.44

$3.57

50 Day Range

MA: $3.34

$3.03

$3.72

52 Week Range

Now: $3.46

$2.88

$17.00

Volume

56,732 shs

Average Volume

183,540 shs

Market Capitalization

$58.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Mural Oncology?: Mural Oncology's top insider shareholders include:
Caroline Loew (CEO)
Adam D Cutler (CFO)
Maiken Keson-Brookes (Insider)
Learn More about top insider investors at Mural Oncology.